CTI provides this data for informational and research purposes only. The data is not intended for trading purposes. Neither CTI nor any of its data content providers shall be liable for any errors or delays in the content, or for any actions in reliance thereon. The continued accuracy of this material beyond the date of issuance and posting on the website is not assured. CTI has no intention of updating this information and specifically disclaims any duty to do so. These documents may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties.
|Investor Relations Contacts|
|Dec 04, 2013||Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI® (pixantrone) in Germany|
|Dec 02, 2013||Cell Therapeutics Receives $5 Million Milestone Payment for TRISENOX®|
|Nov 18, 2013||Cell Therapeutics to Present at Upcoming Investor Conferences|
|Nov 15, 2013||Baxter and Cell Therapeutics Announce Worldwide Strategic Collaboration to Develop and Commercialize Pacritinib|
|Nov 15, 2013||Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership|
You are now leaving this website. If you would like to continue, click Continue.CancelContinue